Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC)

Non-small-cell lung cancer (NSCLC) mortality and new case rates are both on the rise. Most patients have fewer treatment options accessible due to side effects from drugs and the emergence of drug resistance. Bedaquiline (BQ), a drug licensed by the FDA to treat tuberculosis (TB), has demonstrated h...

Descripción completa

Detalles Bibliográficos
Autores principales: Najib Ullah, Shehla Nasar Mir, Afzal, Obaid, Altamimi, Abdulmalik Saleh Alfawaz, Alossaimi, Manal A., Almalki, Waleed H, Alzahrani, Abdulaziz, Barkat, Md. Abul, Almeleebia, Tahani M., Alshareef, Hanan, Shorog, Eman M., Khan, Gyas, Singh, Tanuja, Singh, J. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534335/
https://www.ncbi.nlm.nih.gov/pubmed/37765117
http://dx.doi.org/10.3390/ph16091309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534335/
https://www.ncbi.nlm.nih.gov/pubmed/37765117
http://dx.doi.org/10.3390/ph16091309

Ejemplares similares